Altered whole blood thrombin generation and hyperresponsive platelets in patients with pancreatic cancer
- 21 January 2024
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 22 (4) , 1132-1144
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Venous thromboembolism in cancer patients: ESMO Clinical Practice GuidelineAnnals of Oncology, 2023
- Mechanisms of thrombosis in pancreatic ductal adenocarcinomaBest Practice & Research Clinical Haematology, 2022
- Prevalence Of Anemia In Patients With Pancreas, Liver And Biliary Cancers And Their Relationship With The Inflammatory ResponseHPB, 2019
- Gemcitabine plus nab-paclitaxel vs. FOLFIRINOX for patients with advanced pancreatic cancerCancer Chemotherapy and Pharmacology, 2018
- Incidence of venous thromboembolism (VTE) in ambulatory pancreatic cancer patients receiving chemotherapy and analysis of Khorana’s predictive modelClinical and Translational Oncology, 2014
- Analysis of incidence and clinical outcomes in patients with thromboembolic events and invasive exocrine pancreatic cancerCancer, 2011
- Epidemiology of cancer-related venous thromboembolismBest Practice & Research Clinical Haematology, 2009
- High risk of venous thrombosis in patients with pancreatic cancer: A cohort study of 202 patientsEuropean Journal of Cancer, 2006
- Risk factors for chemotherapy‐associated venous thromboembolism in a prospective observational studyCancer, 2005
- The European Cancer Anaemia Survey (ECAS): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patientsEuropean Journal of Cancer, 2004